{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:15:35Z","timestamp":1790410535500,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001284","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000}}],"reference-count":91,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001284.pub2","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T18:26:21Z","timestamp":1484159181000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma"],"prefix":"10.1002","volume":"2017","author":[{"given":"Scott W","family":"Kirkland","sequence":"first","affiliation":[{"name":"University of Alberta; Department of Emergency Medicine; Edmonton AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Vandenberghe","sequence":"additional","affiliation":[{"name":"University of Alberta; Department of Emergency Medicine; Edmonton AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Voaklander","sequence":"additional","affiliation":[{"name":"University of Alberta; Department of Emergency Medicine; Edmonton AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Nikel","sequence":"additional","affiliation":[{"name":"University of Alberta; Department of Emergency Medicine; Edmonton AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Campbell","sequence":"additional","affiliation":[{"name":"University of Alberta; John W. Scott Health Sciences Library; Edmonton AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H","family":"Rowe","sequence":"additional","affiliation":[{"name":"University of Alberta; Department of Emergency Medicine; Edmonton AB Canada"},{"name":"University of Alberta; School of Public Heath; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0001|cit1","first-page":"353","article-title":"Efficacy of nebulised ipratropium in acute bronchial asthma","volume":"3","author":"Aggarwal","year":"2002","journal-title":"Journal, Indian Academy of Clinical Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001284.pub2-BIB0002|cit2","first-page":"44","article-title":"Treatment with anticholinergics in the asthmatic crisis","volume":"27","author":"Canete","year":"1991","journal-title":"Archivos De Bronconeumologia"},{"issue":"10","key":"10.1002\/14651858.CD001284.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3109\/02770903.2010.517337","article-title":"Levelbuterol versus lebalbuterol plus ipratropium in the treatment of severe acute asthma","volume":"47","author":"Cydulka","year":"2010","journal-title":"Journal of Asthma"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1553-2712.1997.tb03715.x","article-title":"Efficacy of atropine sulfate in combination with albuterol in the treatment for acute asthma","volume":"4","author":"Diaz","year":"1997","journal-title":"Academic Emergency Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1378\/chest.111.2.311","article-title":"The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group","volume":"111","author":"FitzGerald","year":"1997","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0091-6749(97)70219-7","article-title":"Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma","volume":"100","author":"Garrett","year":"1997","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0007|cit7","first-page":"345","article-title":"Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma","volume":"22","author":"Hossain","year":"2013","journal-title":"Mymensingh Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD001284.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/02770909909065151","article-title":"Comparison between fenoterol and fenoterol plus oxitropium bromide delivered by metered-dose inhaler with inspirease to relieve acute asthma attack","volume":"36","author":"Kamei","year":"1999","journal-title":"Journal of Asthma"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1378\/chest.110.3.611","article-title":"A comparison of ipratropium and albuterol vs. albuterol alone for the treatment of acute asthma","volume":"110","author":"Karpel","year":"1996","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.29309\/TPMJ\/2007.14.04.4810","article-title":"Acute severe asthma; salbutamol plus ipratropium bromide nebulization versus salbutomol nebulization alone","volume":"14","author":"Kohistani","year":"2007","journal-title":"Professional Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0196-0644(98)70308-7","article-title":"Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial","volume":"31","author":"Lin","year":"1998","journal-title":"Annals of Emergency Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001284.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1067\/mai.2000.108910","article-title":"Efficacy of adding multiple doses of oxitropium bromide to salbutomol delivered by means of a metered-dose inhaler with a spacer device in adults with acute severe asthma","volume":"106","author":"Nakano","year":"2000","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"8652","key":"10.1002\/14651858.CD001284.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(89)90126-8","article-title":"Nebulised salbutomol with and without ipratropium bromide in acute airflow obstruction","volume":"333","author":"O'Driscoll","year":"1989","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD001284.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1378\/chest.99.5.1084","article-title":"Nebulized atropine sulfate in the treatment of acute asthma","volume":"99","author":"Owens","year":"1991","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0015|cit15","first-page":"129","article-title":"First-line therapy for adult patient with acute asthma receiving a multiple-dose regime of ipratropium bromide plus salbutamol in the emergency department","volume":"20","author":"Rahman","year":"2006","journal-title":"Indian Journal of Allergy Asthma and Immunology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001284.pub2-BIB0016|cit16","first-page":"56","article-title":"A newer treatment regime for adult acute asthmatics with inhaled ipratropium bromide and salbutamol in multiple intermittent doses using a volumetric spacer in emergency setting","volume":"15","author":"Rashid","year":"2010","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(87)90378-0","article-title":"Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room","volume":"82","author":"Rebuck","year":"1987","journal-title":"American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001284.pub2-BIB0018|cit18","first-page":"175","article-title":"Treatment or asthma with high doses of salbutamol and ipratropium bromide administered through metered dose inhaler and holding chamber","volume":"8","author":"Rodrigo Gorina","year":"1995","journal-title":"Paciente Critico"},{"issue":"6","key":"10.1002\/14651858.CD001284.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1164\/ajrccm.161.6.9908115","article-title":"First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department","volume":"161","author":"Rodrigo","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jemermed.2006.05.025","article-title":"A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma","volume":"31","author":"Salo","year":"2006","journal-title":"Journal of Emergency Medicine"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD001284.pub2-BIB0021|cit21","first-page":"A37","article-title":"Ipratropium bromide plus salbutamol in the emergency management of acute asthma exacerbation (AAE)","volume":"169","author":"Solarte","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.97.2.425","article-title":"Nebulized ipratropium in the treatment of acute asthma","volume":"97","author":"Summers","year":"1990","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1378\/chest.115.4.937","article-title":"Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial","volume":"115","author":"Weber","year":"1999","journal-title":"Chest"},{"issue":"11","key":"10.1002\/14651858.CD001284.pub2-BIB0024|cit24","first-page":"71","article-title":"Terbutaline and ipratropium for nebulization","volume":"3","author":"Anonymous","year":"1994","journal-title":"Prescire International"},{"issue":"7","key":"10.1002\/14651858.CD001284.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/jpc.12669","article-title":"Combined anti-cholinergic and short-acting beta-agonist therapy reduces hospital admissions for acute asthma","volume":"50","author":"Barrett","year":"2014","journal-title":"Journal of Paediatric Child Health"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0022-3476(85)80033-0","article-title":"Combined salbutomol and ipratropium bromide by inhalation in the treatment of severe acute asthma","volume":"107","author":"Beck","year":"1985","journal-title":"Journal of Pediatrics"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001284.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000195115","article-title":"The combination of fenoterol and ipratropium bromide in bronchial asthma: Comparison of the acute effects of two different dosages","volume":"50","author":"Bonsignore","year":"1986","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0028|cit28","first-page":"338s","article-title":"Nebulized ipratropium bromide in the treatment of acute attacks of asthma and exacerbation of chronic bronchitis","volume":"1","author":"Bourcereau","year":"1988","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2222.1988.tb02853.x","article-title":"Need for theophylline in severe steroid-requiring asthmatics","volume":"18","author":"Brenner","year":"1998","journal-title":"Clinical Allergy"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/thx.43.4.300","article-title":"Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma","volume":"43","author":"Britton","year":"1988","journal-title":"Thorax"},{"issue":"1","key":"10.1002\/14651858.CD001284.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.88.1.24","article-title":"Nebulized ipratropium bromide in the treatment of acute asthma","volume":"88","author":"Bryant","year":"1985","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0952-0600(90)90032-E","article-title":"Oxitropium bromide: An acute dose response study of a new anticholinergic drug in combination with fenoterol in asthma and chronic bronchitis","volume":"3","author":"Bryant","year":"1990","journal-title":"Pulmonary Pharmacology"},{"issue":"11","key":"10.1002\/14651858.CD001284.pub2-BIB0033|cit33","first-page":"657","article-title":"Effects of ipratropium bromide (IPB) and its combination with salbutamol sulfate (SAS) in acute asthmatic attack","volume":"28","author":"Chen","year":"1989","journal-title":"Zhonghua Nei Ke Za Zhi [Chinese Journal of Internal Medicine]"},{"issue":"5","key":"10.1002\/14651858.CD001284.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1081\/JAS-120004030","article-title":"Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma","volume":"39","author":"Chhabra","year":"2002","journal-title":"Journal of Asthma"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0196-0644(94)70039-7","article-title":"Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of asthma","volume":"23","author":"Cydulka","year":"1994","journal-title":"Annals of Emergency Medicine"},{"issue":"56","key":"10.1002\/14651858.CD001284.pub2-BIB0036|cit36","first-page":"1010","article-title":"Acute asthma in Buenos Aires","volume":"40","author":"Garcia","year":"2012","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"91003","DOI":"10.1378\/chest.134.4_MeetingAbstracts.p91003","article-title":"Evaluating role of inhaled magnesium sulphate as an adjunct to salbutamol and ipratropium in severe acute asthma","volume":"134","author":"Gaur","year":"2008","journal-title":"Chest"},{"issue":"5","key":"10.1002\/14651858.CD001284.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1378\/chest.98.5.1095","article-title":"Comparison of aerosolized glycopyrrolate and metaproterenol in acute asthma","volume":"98","author":"Gilman","year":"1990","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1378\/chest.94.4.718","article-title":"Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma?","volume":"94","author":"Higgins","year":"1988","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0040|cit40","first-page":"651","article-title":"Bronchodilator response to several doses of ipratropium bromide in asthmatics and bronchitis","volume":"33","author":"Hunt","year":"1983","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0007-0971(88)90087-3","article-title":"Nebulization versus injection in ambulatory treatment of acute asthma: A comparative study","volume":"82","author":"Janson","year":"1988","journal-title":"British Journal of Diseases of the Chest"},{"issue":"11","key":"10.1002\/14651858.CD001284.pub2-BIB0042|cit42","first-page":"385","article-title":"Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide","volume":"130","author":"Kaik","year":"1980","journal-title":"Wiener Medizinische Wochenschrift"},{"issue":"5","key":"10.1002\/14651858.CD001284.pub2-BIB0043|cit43","first-page":"727","article-title":"A comparison of atropine sulfate and metaproterenol sulfate in the emergency treatment of asthma","volume":"133","author":"Karpel","year":"1986","journal-title":"American Review of Respiratory Diseases"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2011.04.039","article-title":"Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial","volume":"128","author":"Kerstjens","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD001284.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5863\/1551-6776-20.1.66","article-title":"Continuous inhalation of ipratropium bromide for acute asthma refractory to \u00df2-agonist treatment","volume":"20","author":"Koumbourlis","year":"2015","journal-title":"Journal of Pediatric Pharmacological and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1378\/chest.114.2.365","article-title":"The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: A pooled analysis of three trials","volume":"114","author":"Lanes","year":"1998","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0007-0971(83)90022-0","article-title":"Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma","volume":"77","author":"Leahy","year":"1983","journal-title":"British Journal of Diseases of the Chest"},{"issue":"5","key":"10.1002\/14651858.CD001284.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0196-0644(99)70334-3","article-title":"Rapid improvement of peak flow in asthmatic patients treated with parenteral methylprednisolone in the emergency department: A randomized controlled study","volume":"33","author":"Lin","year":"1999","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0049|cit49","unstructured":"Lin RY Pesola GR Bakalchuk L Curry A Nelson M Lee H The effect of early parenteral administration of corticosteroids in severe asthma: A study not employing concomitant ipratropium treatment Internet Journal of Asthma, Allergy and Immunology 2004"},{"issue":"1","key":"10.1002\/14651858.CD001284.pub2-BIB0050|cit50","first-page":"24","article-title":"Relative efficacy of nebulized ipratropium bromide and fenoterol in acute severe asthma","volume":"77","author":"Louw","year":"1990","journal-title":"South African Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000196686","article-title":"Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (berodual) for the delivery of a fixed combination of fenoterol\/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma","volume":"64","author":"Maesen","year":"1997","journal-title":"Respiration"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001284.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000195152","article-title":"Blind randomized cross-over comparative study of salbutamol and the combination fenoterol-ipratropium IK6 in patients with bronchial asthma","volume":"50","author":"Mazzei","year":"1986","journal-title":"Respiration"},{"issue":"Suppl 19","key":"10.1002\/14651858.CD001284.pub2-BIB0053|cit53","first-page":"455s","article-title":"Combination of nebulized ipratropium bromide and beta-agonists in the treatment of acute severe asthma","volume":"8","author":"Nana","year":"1995","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1378\/chest.98.2.295","article-title":"Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy","volume":"96","author":"Patrick","year":"1990","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0002-9343(99)00243-0","article-title":"A meta-analysis of the effects of ipratropium bromide in adults with acute asthma","volume":"107","author":"Rodrigo","year":"1999","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001284.pub2-BIB0056|cit56","first-page":"571","article-title":"A comparison of fenoterol and fenoterol-ipratropium nebulisation treatment in acute asthma","volume":"13","author":"Roeseler","year":"1987","journal-title":"Acta Therapeutica"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0057|cit57","first-page":"405","article-title":"Acute effects of fenoterol (Berotec) and ipratropium bromide (Atrovent) alone and in combination on bronchial hyper-responsiveness in asthmatic subjects","volume":"263","author":"Salome","year":"1988","journal-title":"Progress in Clinical and Biological Research"},{"issue":"6","key":"10.1002\/14651858.CD001284.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1378\/chest.73.6_Supplement.982","article-title":"Double blind comparison of acute bronchial and ventilation-perfusion changes to atrovent and isoproterenol","volume":"73","author":"Schlueter","year":"1978","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0059|cit59","unstructured":"Schneider J Matsuda K House SL Ferguson I Aubuchon K Lewis L Dyspnea scores may be a better predictor of hospital admissions than FEV1 for patients with acute asthma exacerbations Academic Emergency Medicine 2012 S312"},{"issue":"1","key":"10.1002\/14651858.CD001284.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0196-0644(99)70266-0","article-title":"The role of ipratropium bromide in the emergency management of acute asthma exacerbation: A meta analysis of randomized clinical trials","volume":"34","author":"Stoodley","year":"1999","journal-title":"Annals of Emergency Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001284.pub2-BIB0061|cit61","first-page":"S75","article-title":"Pre-hospital management of patients with history of asthma and COPD in one Canadian urban setting","volume":"15","author":"Tamura","year":"2014","journal-title":"Canadian Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0062|cit62","unstructured":"Toda M Fukuda T Motojima S Makino S Effect of the combination of fenoterol with oxitropium on asthmatic patients with acute air-way obstructions European Respiratory Journal 1992 209s"},{"issue":"39","key":"10.1002\/14651858.CD001284.pub2-BIB0063|cit63","first-page":"4228","article-title":"Acute test comparing ipratropium bromide (SCH 1000), fenoterol, and placebo, by measured dose aerosol, in obstructive lung disease","volume":"24","author":"Vogt","year":"1974","journal-title":"Therapiewoche"},{"issue":"6264","key":"10.1002\/14651858.CD001284.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.282.6264.598","article-title":"Ipratropium bromide in acute asthma","volume":"282","author":"Ward","year":"1981","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0065|cit65","first-page":"197","article-title":"Comparison of fenoterol, ipratropium bromide and their combination in asthma","volume":"41","author":"Youngchaiyud","year":"1989","journal-title":"Siriraj Hospital Gazette"},{"issue":"7185","key":"10.1002\/14651858.CD001284.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/bmj.318.7185.738","article-title":"Ipratropium does indeed reduce admissions to hospital with severe asthma","volume":"318","author":"Zaritsky","year":"1999","journal-title":"British Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD001284.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1081\/JAS-100107116","article-title":"The use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: A systematic review","volume":"38","author":"Aaron","year":"2001","journal-title":"Journal of Asthma"},{"issue":"1","key":"10.1002\/14651858.CD001284.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1067\/mai.2002.125489","article-title":"Inadequate use of asthma medication in the United States: Results of the Asthma in America national population survey","volume":"110","author":"Adams","year":"2002","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD001284.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1378\/chest.130.1_suppl.4S","article-title":"The global burden of asthma","volume":"130","author":"Braman","year":"2006","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0070|cit70","unstructured":"Global Initiative for Asthma Global Strategy for Asthma Management and Prevention, 2016 www.ginaasthma.org"},{"issue":"7454","key":"10.1002\/14651858.CD001284.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Grade Working Group","year":"2004","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0072|cit72","unstructured":"McMaster University GRADEpro [www.gradepro.org]. Version [3.6] 2014"},{"issue":"8","key":"10.1002\/14651858.CD001284.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000060.pub2","article-title":"Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children","author":"Grif\ufb01ths","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD001284.pub2-BIB0074|cit74","first-page":"509","article-title":"Quality of care for acute asthma in emergency departments in Japan: A multicenter observational study","volume":"1","author":"Hasegawa","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0075|cit75","unstructured":"Higgins JPT Green S Cochrane handbook for systematic reviews of interventions version 5.1 The Cochrane Collaboration 2011 Available from www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD001284.pub2-BIB0076|cit76","first-page":"821","article-title":"Direct and indirect costs of asthma in Canada","volume":"154","author":"Krahn","year":"1996","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD001284.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1067\/mai.2003.30","article-title":"Asthma control in the Asia-Pacific region: The Asthma Insights and reality in Asia-Pacific study","volume":"111","author":"Lai","year":"2003","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0078|cit78","first-page":"123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Medicine"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1378\/chest.93.1.123","article-title":"Fifteen year interval spirometric evaluation of the Oregon pedictive equations","volume":"92","author":"Morris","year":"1988","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD001284.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1590\/S1020-49892005000300007","article-title":"Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey","volume":"17","author":"Neffen","year":"2005","journal-title":"Revista Panamericana de Salud Publica"},{"issue":"1","key":"10.1002\/14651858.CD001284.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00003495-198938010-00004","article-title":"Salbutamol in the 1980s. A reappraisal of its clinical efficacy","volume":"38","author":"Price","year":"1989","journal-title":"Drugs"},{"issue":"5","key":"10.1002\/14651858.CD001284.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1183\/09031936.00.16580200","article-title":"Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study","volume":"16","author":"Rabe","year":"2000","journal-title":"European Respiratory Journal"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001284.pub2-BIB0083|cit83","first-page":"2","article-title":"Newer effective treatment for adult patients with acute asthma with a multi-dose regimen of ipratropium bromide plus salbutamol using a spacer device in emergency department","volume":"17","author":"Rashid","year":"2012","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD001284.pub2-BIB0084|cit84","unstructured":"The Cochrane Collaboration Review Manager (RevMan) Version 5.3. Copenhagen: The Nordic Cochrane Centre 2014"},{"issue":"9","key":"10.1002\/14651858.CD001284.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/thx.2005.047803","article-title":"Anticholinergics in the treatment of children and adults with acute asthma: A systematic review with meta-analysis","volume":"60","author":"Rodrigo","year":"2005","journal-title":"Thorax"},{"issue":"3","key":"10.1002\/14651858.CD001284.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1067\/mem.2000.105659","article-title":"Intravenous magnesium sulfate treatment for acute asthma in the emergency department: A systematic review of the literature","volume":"36","author":"Rowe","year":"2000","journal-title":"Annals of Emergency Medicine"},{"issue":"1. Art. No.: CD","key":"10.1002\/14651858.CD001284.pub2-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001490","article-title":"Magnesium sulfate for treating exacerbations of acute asthma in the emergency department","author":"Rowe","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001284.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1155\/2010\/178549","article-title":"Admissions to Canadian hospitals for acute asthma: A prospective, multicentre study","volume":"17","author":"Rowe","year":"2010","journal-title":"Canadian Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD001284.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1399-3003.1999.14a06.x","article-title":"What are the minimal important changes for asthma measures in a clinical trial?","volume":"14","author":"Santanello","year":"1999","journal-title":"European Respiratory Journal"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD001284.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1164\/ajrccm.156.3.9611072","article-title":"A national estimate of the economic costs of asthma","volume":"156","author":"Smith","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001284.pub2-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001284","article-title":"Inhaled beta2-agonist and anticholinergic agents for emergency management of asthma in adults","author":"Spooner","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001284.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T03:48:44Z","timestamp":1681444124000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001284.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001284.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]}}}